Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term:EC 2.* (transferase) inhibitor
go back to main search page
Accession:CHEBI:71300 term browser browse the term
Definition:An enzyme inhibitor that inhibits the action of a transferase (EC 2.*)
Synonyms:related_synonym: EC 2 inhibitor;   EC 2 inhibitors;   EC 2.* (transferase) inhibitors;   transferase inhibitor;   transferase inhibitors
 xref: Wikipedia:Transferase


show annotations for term's descendants           Sort by:
5'-phosphopyridoxal-6-azobenzene-2,4-disulfonic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G P2RY2 purinergic receptor P2Y2 multiple interactions EXP pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid inhibits the reaction [[Uridine Triphosphate results in increased activity of P2RY2 protein] which results in increased abundance of Arachidonic Acid]; pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid inhibits the reaction [[Uridine Triphosphate results in increased activity of P2RY2 protein] which results in increased abundance of Cyclic AMP] CTD PMID:10604969 NCBI chr21:24,987,568...25,009,754
Ensembl chr21:24,992,848...24,996,059 		JBrowse link
anthra[1,9-cd]pyrazol-6(2H)-one term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CLDN4 claudin 4 multiple interactions EXP pyrazolanthrone inhibits the reaction [Hydrogen Peroxide results in increased expression of CLDN4 protein]; pyrazolanthrone inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein] CTD PMID:23816505 NCBI chr 6:6,492,706...6,506,750
Ensembl chr 6:6,493,513...6,494,145 		JBrowse link
G JUN Jun proto-oncogene, AP-1 transcription factor subunit multiple interactions EXP pyrazolanthrone inhibits the reaction [Sodium Chloride promotes the reaction [SP1 protein binds to JUN protein]] CTD PMID:23816505 NCBI chr 5:50,966,698...50,968,939 JBrowse link
G MAPK8 mitogen-activated protein kinase 8 multiple interactions EXP pyrazolanthrone inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK8 protein]; pyrazolanthrone inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK8 protein] CTD PMID:23816505 NCBI chr28:323,361...410,367
Ensembl chr28:368,513...406,401 		JBrowse link
G MAPK9 mitogen-activated protein kinase 9 multiple interactions EXP pyrazolanthrone inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK9 protein]; pyrazolanthrone inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK9 protein] CTD PMID:23816505 NCBI chr11:1,443,528...1,480,501
Ensembl chr11:1,443,547...1,478,119 		JBrowse link
G SP1 Sp1 transcription factor multiple interactions EXP pyrazolanthrone inhibits the reaction [Sodium Chloride promotes the reaction [SP1 protein binds to JUN protein]]; pyrazolanthrone inhibits the reaction [Sodium Chloride results in increased expression of SP1 protein] CTD PMID:23816505 NCBI chr27:1,802,587...1,861,187
Ensembl chr27:1,805,184...1,847,226 		JBrowse link
genistein term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CFTR CF transmembrane conductance regulator decreases activity EXP Genistein results in decreased activity of CFTR protein CTD PMID:15496164 NCBI chr14:56,290,417...56,452,919
Ensembl chr14:56,290,275...56,453,977 		JBrowse link
G CPNE6 copine 6 decreases activity EXP Genistein results in decreased activity of DHRS4 protein CTD PMID:17827741 NCBI chr 8:4,046,532...4,058,498
Ensembl chr 8:4,046,544...4,084,744 		JBrowse link
glyburide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CFTR CF transmembrane conductance regulator decreases activity EXP Glyburide results in decreased activity of CFTR protein CTD PMID:15496164 NCBI chr14:56,290,417...56,452,919
Ensembl chr14:56,290,275...56,453,977 		JBrowse link
luteolin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CCL17 C-C motif chemokine ligand 17 multiple interactions EXP [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of CCL17 mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] results in increased methylation of CCL17 promoter CTD PMID:33763461 NCBI chr 2:59,001,463...59,014,347
Ensembl chr 2:59,001,464...59,005,230 		JBrowse link
G CCL2 C-C motif chemokine ligand 2 multiple interactions EXP [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of CCL2 mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] results in increased methylation of CCL2 promoter CTD PMID:33763461 NCBI chr 9:39,008,187...39,009,932 JBrowse link
G IL13 interleukin 13 multiple interactions EXP [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of CCL17 mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of CCL2 mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of IL31RA mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of TSLP mRNA] CTD PMID:33763461 NCBI chr11:20,957,870...20,961,391
Ensembl chr11:20,958,464...20,961,388 		JBrowse link
G IL31 interleukin 31 multiple interactions EXP [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of CCL17 mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of CCL2 mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of IL31RA mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of TSLP mRNA] CTD PMID:33763461 NCBI chr26:7,173,151...7,175,195
Ensembl chr26:7,172,451...7,175,195 		JBrowse link
G IL31RA interleukin 31 receptor A multiple interactions EXP [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of IL31RA mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] results in increased methylation of IL31RA promoter CTD PMID:33763461 NCBI chr 2:43,113,194...43,198,200
Ensembl chr 2:43,144,071...43,193,293 		JBrowse link
G IL4 interleukin 4 multiple interactions EXP [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of CCL17 mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of CCL2 mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of IL31RA mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of TSLP mRNA] CTD PMID:33763461 NCBI chr11:20,972,693...20,981,539
Ensembl chr11:20,972,690...20,981,534 		JBrowse link
G TSLP thymic stromal lymphopoietin multiple interactions EXP [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of TSLP mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] results in increased methylation of TSLP promoter CTD PMID:33763461 NCBI chr 3:1,502,469...1,507,696
Ensembl chr 3:1,503,188...1,507,696 		JBrowse link
LY294002 term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G PIK3CG phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma multiple interactions EXP 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Norepinephrine results in increased activity of PIK3CG protein] which results in increased chemical synthesis of phosphatidylinositol 3-phosphate]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Norepinephrine results in increased activity of PIK3CG protein] CTD PMID:15958164 NCBI chr18:13,576,966...13,611,748
Ensembl chr18:13,570,999...13,611,141 		JBrowse link
G PRKCZ protein kinase C zeta multiple interactions EXP 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Clonidine results in increased phosphorylation of PRKCZ protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Norepinephrine results in increased phosphorylation of PRKCZ protein] CTD PMID:15958164 NCBI chr 5:57,012,020...57,113,346
Ensembl chr 5:57,012,070...57,112,664 		JBrowse link
masitinib term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCA5 ATP binding cassette subfamily A member 5 increases expression EXP masitinib results in increased expression of ABCA5 mRNA CTD PMID:22747577 NCBI chr 9:15,708,070...15,781,100
Ensembl chr 9:15,420,835...15,783,045 		JBrowse link
G ABHD14A abhydrolase domain containing 14A increases expression EXP masitinib results in increased expression of ABHD14A mRNA CTD PMID:22747577 NCBI chr20:37,738,500...37,744,689 JBrowse link
G ABITRAM actin binding transcription modulator decreases expression EXP masitinib results in decreased expression of ABITRAM mRNA CTD PMID:22747577 NCBI chr11:64,094,653...64,100,078
Ensembl chr11:64,094,721...64,109,421 		JBrowse link
G ABLIM1 actin binding LIM protein 1 increases expression EXP masitinib results in increased expression of ABLIM1 mRNA CTD PMID:22747577 NCBI chr28:25,260,323...25,543,369
Ensembl chr28:25,260,873...25,545,304 		JBrowse link
G ACAT2 acetyl-CoA acetyltransferase 2 decreases expression EXP masitinib results in decreased expression of ACAT2 mRNA CTD PMID:22747577 NCBI chr 1:49,011,665...49,029,368
Ensembl chr 1:49,011,706...49,029,327 		JBrowse link
G ACSM3 acyl-CoA synthetase medium chain family member 3 increases expression EXP masitinib results in increased expression of ACSM3 mRNA CTD PMID:22747577 NCBI chr 6:24,558,010...24,594,326
Ensembl chr 6:24,558,142...24,582,728 		JBrowse link
G ACTL7A actin like 7A increases expression EXP masitinib results in increased expression of ACTL7A mRNA CTD PMID:22747577 NCBI chr11:64,031,305...64,033,908
Ensembl chr11:64,032,358...64,033,788 		JBrowse link
G ACTR2 actin related protein 2 decreases expression EXP masitinib results in decreased expression of ACTR2 protein CTD PMID:22747577 NCBI chr10:64,696,068...64,733,027
Ensembl chr10:64,696,111...64,730,553 		JBrowse link
G ADPRH ADP-ribosylarginine hydrolase increases expression EXP masitinib results in increased expression of ADPRH mRNA CTD PMID:22747577 NCBI chr33:23,218,633...23,226,844
Ensembl chr33:23,218,101...23,224,667 		JBrowse link
G AGA aspartylglucosaminidase increases expression EXP masitinib results in increased expression of AGA mRNA CTD PMID:22747577 NCBI chr16:52,314,860...52,324,879
Ensembl chr16:52,314,535...52,324,894 		JBrowse link
G AGO2 argonaute RISC catalytic component 2 decreases expression EXP masitinib results in decreased expression of AGO2 mRNA CTD PMID:22747577 NCBI chr13:35,169,243...35,230,252
Ensembl chr13:35,180,912...35,268,577 		JBrowse link
G AGRN agrin increases expression EXP masitinib results in increased expression of AGRN mRNA CTD PMID:22747577 NCBI chr 5:56,239,621...56,273,679
Ensembl chr 5:56,239,701...56,272,745 		JBrowse link
G AIG1 androgen induced 1 increases expression EXP masitinib results in increased expression of AIG1 mRNA CTD PMID:22747577 NCBI chr 1:34,643,994...34,884,445
Ensembl chr 1:34,643,764...34,884,119 		JBrowse link
G ALAS2 5'-aminolevulinate synthase 2 increases expression EXP masitinib results in increased expression of ALAS2 mRNA CTD PMID:22747577 NCBI chr  X:46,703,477...46,731,767
Ensembl chr  X:46,703,477...46,723,529 		JBrowse link
G ALDH5A1 aldehyde dehydrogenase 5 family member A1 decreases expression EXP masitinib results in decreased expression of ALDH5A1 mRNA CTD PMID:22747577 NCBI chr35:22,560,005...22,590,996
Ensembl chr35:22,560,008...22,587,875 		JBrowse link
G AMN1 antagonist of mitotic exit network 1 homolog increases expression EXP masitinib results in increased expression of AMN1 mRNA CTD PMID:22747577 NCBI chr27:17,044,301...17,100,444
Ensembl chr27:17,044,309...17,361,570 		JBrowse link
G ANKRD26 ankyrin repeat domain containing 26 increases expression EXP masitinib results in increased expression of ANKRD26 mRNA CTD PMID:22747577 NCBI chr 2:6,230,466...6,402,360 JBrowse link
G ANP32E acidic nuclear phosphoprotein 32 family member E decreases expression EXP masitinib results in decreased expression of ANP32E mRNA CTD PMID:22747577 NCBI chr17:59,460,864...59,482,467
Ensembl chr17:59,462,766...59,477,936 		JBrowse link
G ANXA1 annexin A1 increases expression EXP masitinib results in increased expression of ANXA1 protein CTD PMID:22747577 NCBI chr 1:84,744,159...84,763,011
Ensembl chr 1:84,744,163...84,763,011 		JBrowse link
G ANXA6 annexin A6 increases expression EXP masitinib results in increased expression of ANXA6 protein CTD PMID:22747577 NCBI chr 4:58,091,186...58,140,102
Ensembl chr 4:58,091,251...58,139,372 		JBrowse link
G ARMC12 armadillo repeat containing 12 increases expression EXP masitinib results in increased expression of ARMC12 mRNA CTD PMID:22747577 NCBI chr12:4,868,831...4,879,801
Ensembl chr12:4,869,774...4,879,793 		JBrowse link
G ASCC1 activating signal cointegrator 1 complex subunit 1 decreases expression EXP masitinib results in decreased expression of ASCC1 mRNA CTD PMID:22747577 NCBI chr 4:22,779,644...22,876,434
Ensembl chr 4:22,779,781...22,874,215 		JBrowse link
G B4GALT7 beta-1,4-galactosyltransferase 7 increases expression EXP masitinib results in increased expression of B4GALT7 mRNA CTD PMID:22747577 NCBI chr11:3,497,860...3,507,513
Ensembl chr11:3,498,153...3,505,034 		JBrowse link
G BIRC5 baculoviral IAP repeat containing 5 decreases expression EXP masitinib results in decreased expression of BIRC5 mRNA CTD PMID:22747577 NCBI chr 9:2,930,308...2,959,307 JBrowse link
G BTBD3 BTB domain containing 3 decreases expression EXP masitinib results in decreased expression of BTBD3 mRNA CTD PMID:22747577 NCBI chr24:10,478,635...10,512,773
Ensembl chr24:10,479,900...10,512,185 		JBrowse link
G CA2 carbonic anhydrase 2 decreases expression EXP masitinib results in decreased expression of CA2 mRNA CTD PMID:22747577 NCBI chr29:31,959,225...31,975,309
Ensembl chr29:31,935,172...31,980,579 		JBrowse link
G CAMK2G calcium/calmodulin dependent protein kinase II gamma increases expression EXP masitinib results in increased expression of CAMK2G mRNA CTD PMID:22747577 NCBI chr 4:24,244,063...24,299,362
Ensembl chr 4:24,245,960...24,299,357 		JBrowse link
G CAPG capping actin protein, gelsolin like increases expression EXP masitinib results in increased expression of CAPG protein CTD PMID:22747577 NCBI chr17:39,619,429...39,640,944
Ensembl chr17:39,619,248...39,640,942 		JBrowse link
G CCT2 chaperonin containing TCP1 subunit 2 decreases expression EXP masitinib results in decreased expression of CCT2 protein CTD PMID:22747577 NCBI chr10:11,560,287...11,586,559
Ensembl chr10:11,560,396...11,578,433 		JBrowse link
G CD5L CD5 molecule like increases expression EXP masitinib results in increased expression of CD5L mRNA CTD PMID:22747577 NCBI chr 7:40,516,190...40,526,528
Ensembl chr 7:40,516,190...40,526,528 		JBrowse link
G CDADC1 cytidine and dCMP deaminase domain containing 1 increases expression EXP masitinib results in increased expression of CDADC1 mRNA CTD PMID:22747577 NCBI chr22:2,443,459...2,489,147
Ensembl chr22:2,436,206...2,489,016 		JBrowse link
G CDKN1A cyclin dependent kinase inhibitor 1A increases expression EXP masitinib results in increased expression of CDKN1A mRNA CTD PMID:22747577 NCBI chr12:5,746,898...5,755,103
Ensembl chr12:5,745,852...5,892,281 		JBrowse link
G CIAPIN1 cytokine induced apoptosis inhibitor 1 decreases expression EXP masitinib results in decreased expression of CIAPIN1 mRNA CTD PMID:22747577 NCBI chr 2:58,977,592...58,992,785
Ensembl chr 2:58,977,676...58,992,581 		JBrowse link
G CIRBP cold inducible RNA binding protein increases expression EXP masitinib results in increased expression of CIRBP mRNA CTD PMID:22747577 NCBI chr20:57,521,609...57,526,526
Ensembl chr20:57,519,119...57,526,435 		JBrowse link
G CLEC2B C-type lectin domain family 2 member B decreases expression EXP masitinib results in decreased expression of CLEC2B mRNA CTD PMID:22747577 NCBI chr27:36,088,754...36,143,581
Ensembl chr27:36,120,134...36,143,040 		JBrowse link
G CMTM7 CKLF like MARVEL transmembrane domain containing 7 increases expression EXP masitinib results in increased expression of CMTM7 mRNA CTD PMID:22747577 NCBI chr23:12,317,636...12,382,836
Ensembl chr23:12,328,303...12,382,837 		JBrowse link
G CORO1A coronin 1A increases expression EXP masitinib results in increased expression of CORO1A protein CTD PMID:22747577 NCBI chr 6:18,161,850...18,167,915
Ensembl chr 6:18,160,601...18,167,818 		JBrowse link
G CPNE1 copine 1 increases expression EXP masitinib results in increased expression of CPNE1 mRNA CTD PMID:22747577 NCBI chr24:24,554,636...24,589,748
Ensembl chr24:24,554,636...24,589,731 		JBrowse link
G CPNE6 copine 6 increases expression EXP masitinib results in increased expression of DHRS4 mRNA CTD PMID:22747577 NCBI chr 8:4,046,532...4,058,498
Ensembl chr 8:4,046,544...4,084,744 		JBrowse link
G CTSK cathepsin K increases expression EXP masitinib results in increased expression of CTSK mRNA CTD PMID:22747577 NCBI chr17:59,928,725...59,938,293
Ensembl chr17:59,929,287...59,938,507 		JBrowse link
G DLA-12 MHC class I DLA-12 increases expression EXP masitinib results in increased expression of DLA-12 mRNA CTD PMID:22747577 NCBI chr12:933,321...936,671
Ensembl chr12:932,613...987,561 		JBrowse link
G DLA-64 MHC class I DLA-64 increases expression EXP masitinib results in increased expression of DLA-64 mRNA CTD PMID:22747577 NCBI chr12:983,573...986,969 JBrowse link
G DLGAP1 DLG associated protein 1 decreases expression EXP masitinib results in decreased expression of DLGAP1 mRNA CTD PMID:22747577 NCBI chr 7:70,082,563...70,949,116
Ensembl chr 7:70,081,885...70,406,213 		JBrowse link
G DLGAP5 DLG associated protein 5 decreases expression EXP masitinib results in decreased expression of DLGAP5 mRNA CTD PMID:22747577 NCBI chr 8:30,998,806...31,038,614
Ensembl chr 8:30,994,402...31,036,540 		JBrowse link
G DPCD deleted in primary ciliary dyskinesia homolog decreases expression EXP masitinib results in decreased expression of DPCD mRNA CTD PMID:22747577 NCBI chr28:14,201,302...14,219,121
Ensembl chr28:14,201,351...14,219,121 		JBrowse link
G DPYSL3 dihydropyrimidinase like 3 decreases expression EXP masitinib results in decreased expression of DPYSL3 mRNA CTD PMID:22747577 NCBI chr 2:41,687,725...41,809,402
Ensembl chr 2:41,690,845...41,802,376 		JBrowse link
G EBPL EBP like increases expression EXP masitinib results in increased expression of EBPL mRNA CTD PMID:22747577 NCBI chr22:2,116,588...2,137,935
Ensembl chr22:2,116,131...2,182,633 		JBrowse link
G EDEM2 ER degradation enhancing alpha-mannosidase like protein 2 increases expression EXP masitinib results in increased expression of EDEM2 mRNA CTD PMID:22747577 NCBI chr24:24,137,228...24,165,995
Ensembl chr24:24,137,228...24,165,968 		JBrowse link
G EIF3A eukaryotic translation initiation factor 3 subunit A decreases expression EXP masitinib results in decreased expression of EIF3A protein CTD PMID:22747577 NCBI chr28:29,290,668...29,326,851
Ensembl chr28:29,291,422...29,326,701 		JBrowse link
G EIF4A1 eukaryotic translation initiation factor 4A1 decreases expression EXP masitinib results in decreased expression of EIF4A1 protein CTD PMID:22747577 NCBI chr 5:32,495,606...32,500,805
Ensembl chr 5:32,484,572...32,500,805 		JBrowse link
G EIF5A2 eukaryotic translation initiation factor 5A2 decreases expression EXP masitinib results in decreased expression of EIF5A2 mRNA CTD PMID:22747577 NCBI chr34:35,309,812...35,322,382
Ensembl chr34:35,314,172...35,322,392 		JBrowse link
G ELSPBP1 epididymal sperm binding protein 1 increases expression EXP masitinib results in increased expression of ELSPBP1 mRNA CTD PMID:22747577 NCBI chr 1:108,159,609...108,187,224
Ensembl chr 1:108,159,611...108,188,076 		JBrowse link
G ETFDH electron transfer flavoprotein dehydrogenase decreases expression EXP masitinib results in decreased expression of ETFDH mRNA CTD PMID:22747577 NCBI chr15:55,752,170...55,781,118
Ensembl chr15:55,752,200...55,792,105 		JBrowse link
G GGT1 gamma-glutamyltransferase 1 increases expression EXP masitinib results in increased expression of GGT1 mRNA CTD PMID:22747577 NCBI chr26:28,301,455...28,315,029 JBrowse link
G GKN1 gastrokine 1 increases expression EXP masitinib results in increased expression of GKN1 mRNA CTD PMID:22747577 NCBI chr10:67,788,329...67,793,445
Ensembl chr10:67,788,110...67,793,589 		JBrowse link
G GMFB glia maturation factor beta decreases expression EXP masitinib results in decreased expression of GMFB mRNA CTD PMID:22747577 NCBI chr 8:30,394,020...30,408,408
Ensembl chr 8:30,359,499...30,408,357 		JBrowse link
G GSTA4 glutathione S-transferase alpha 4 increases expression EXP masitinib results in increased expression of GSTA4 mRNA CTD PMID:22747577 NCBI chr12:20,426,724...20,443,200
Ensembl chr12:20,426,726...20,443,200 		JBrowse link
G GXYLT1 glucoside xylosyltransferase 1 decreases expression EXP masitinib results in decreased expression of GXYLT1 mRNA CTD PMID:22747577 NCBI chr27:11,754,609...11,810,245
Ensembl chr27:11,765,072...11,807,787 		JBrowse link
G HEBP2 heme binding protein 2 decreases expression EXP masitinib results in decreased expression of HEBP2 mRNA CTD PMID:22747577 NCBI chr 1:30,716,395...30,724,814
Ensembl chr 1:30,716,606...30,724,613 		JBrowse link
G HERPUD1 homocysteine inducible ER protein with ubiquitin like domain 1 increases expression EXP masitinib results in increased expression of HERPUD1 mRNA CTD PMID:22747577 NCBI chr 2:59,388,492...59,400,028
Ensembl chr 2:59,388,494...59,400,003 		JBrowse link
G HSP90B1 heat shock protein 90 beta family member 1 increases expression EXP masitinib results in increased expression of HSP90B1 protein CTD PMID:22747577 NCBI chr15:42,456,793...42,474,122
Ensembl chr15:42,456,764...42,579,311 		JBrowse link
G HTR2B 5-hydroxytryptamine receptor 2B increases expression EXP masitinib results in increased expression of HTR2B mRNA CTD PMID:22747577 NCBI chr25:43,042,306...43,056,361
Ensembl chr25:43,042,173...43,056,612 		JBrowse link
G HYAL3 hyaluronidase 3 increases expression EXP masitinib results in increased expression of HYAL3 mRNA CTD PMID:22747577 NCBI chr20:39,041,940...39,047,388
Ensembl chr20:39,042,070...39,047,365 		JBrowse link
G IGFBP7 insulin like growth factor binding protein 7 increases expression EXP masitinib results in increased expression of IGFBP7 mRNA CTD PMID:22747577 NCBI chr13:49,138,406...49,207,235
Ensembl chr13:49,138,402...49,207,394 		JBrowse link
G IL13 interleukin 13 increases expression EXP masitinib results in increased expression of IL13 mRNA CTD PMID:22747577 NCBI chr11:20,957,870...20,961,391
Ensembl chr11:20,958,464...20,961,388 		JBrowse link
G IMMP2L inner mitochondrial membrane peptidase subunit 2 increases expression EXP masitinib results in increased expression of IMMP2L mRNA CTD PMID:22747577 NCBI chr14:50,487,679...51,336,906 JBrowse link
G IRX6 iroquois homeobox 6 increases expression EXP masitinib results in increased expression of IRX6 protein CTD PMID:22747577 NCBI chr 2:60,630,688...60,636,285
Ensembl chr 2:60,630,447...60,636,416 		JBrowse link
G ITGA6 integrin subunit alpha 6 decreases expression EXP masitinib results in decreased expression of ITGA6 mRNA CTD PMID:22747577 NCBI chr36:16,777,363...16,858,725
Ensembl chr36:16,776,863...16,855,449 		JBrowse link
G JAML junction adhesion molecule like decreases expression EXP masitinib results in decreased expression of JAML mRNA CTD PMID:22747577 NCBI chr 5:15,485,378...15,513,457
Ensembl chr 5:15,476,582...15,513,075 		JBrowse link
G JUN Jun proto-oncogene, AP-1 transcription factor subunit increases expression EXP masitinib results in increased expression of JUN mRNA CTD PMID:22747577 NCBI chr 5:50,966,698...50,968,939 JBrowse link
G KCTD19 potassium channel tetramerization domain containing 19 increases expression EXP masitinib results in increased expression of KCTD19 mRNA CTD PMID:22747577 NCBI chr 5:82,060,946...82,093,248
Ensembl chr 5:82,061,449...82,093,246 		JBrowse link
G KLHL5 kelch like family member 5 increases expression EXP masitinib results in increased expression of KLHL5 mRNA CTD PMID:22747577 NCBI chr 3:73,258,925...73,347,262
Ensembl chr 3:73,262,895...73,344,879 		JBrowse link
G LBX2 ladybird homeobox 2 increases expression EXP masitinib results in increased expression of LBX2 mRNA CTD PMID:22747577 NCBI chr17:48,641,630...48,643,411
Ensembl chr17:48,641,674...48,643,239 		JBrowse link
G LIN7C lin-7 homolog C, crumbs cell polarity complex component decreases expression EXP masitinib results in decreased expression of LIN7C mRNA CTD PMID:22747577 NCBI chr21:48,061,446...48,071,458
Ensembl chr21:48,064,929...48,071,429 		JBrowse link
G LOC474850 heat shock 70 kDa protein 1-like increases expression EXP masitinib results in increased expression of HSPA1L mRNA CTD PMID:22747577 NCBI chr12:1,281,164...1,285,010
Ensembl chr12:1,281,472...1,285,440 		JBrowse link
G LOC475707 GPN-loop GTPase 1 decreases expression EXP masitinib results in decreased expression of GPN1 mRNA CTD PMID:22747577 NCBI chr17:21,654,516...21,678,435
Ensembl chr17:21,545,673...21,673,157 		JBrowse link
G LOC478000 phytanoyl-CoA hydroxylase-like increases expression EXP masitinib results in increased expression of PHYH mRNA CTD PMID:22747577 NCBI chr 2:23,185,901...23,206,719
Ensembl chr 2:23,185,782...23,253,497 		JBrowse link
G LOC609402 hemoglobin subunit beta-like increases expression EXP masitinib results in increased expression of HBG1 mRNA CTD PMID:22747577 NCBI chr21:28,187,535...28,188,991 JBrowse link
G LONRF1 LON peptidase N-terminal domain and ring finger 1 increases expression EXP masitinib results in increased expression of LONRF1 mRNA CTD PMID:22747577 NCBI chr16:36,220,324...36,256,896
Ensembl chr16:36,221,156...36,256,897 		JBrowse link
G LRP1 LDL receptor related protein 1 increases expression EXP masitinib results in increased expression of LRP1 mRNA CTD PMID:22747577 NCBI chr10:1,260,256...1,341,705
Ensembl chr10:1,260,719...1,352,271 		JBrowse link
G LRP8 LDL receptor related protein 8 decreases expression EXP masitinib results in decreased expression of LRP8 mRNA CTD PMID:22747577 NCBI chr 5:55,604,878...55,684,666
Ensembl chr 5:55,604,878...55,699,736 		JBrowse link
G LYRM1 LYR motif containing 1 increases expression EXP masitinib results in increased expression of LYRM1 mRNA CTD PMID:22747577 NCBI chr 6:24,428,461...24,460,291
Ensembl chr 6:24,441,307...24,460,331 		JBrowse link
G MAGEF1 MAGE family member F1 decreases expression EXP masitinib results in decreased expression of MAGEF1 mRNA CTD PMID:22747577 NCBI chr34:17,543,381...17,545,089
Ensembl chr34:17,543,906...17,544,868 		JBrowse link
G MOB1B MOB kinase activator 1B decreases expression EXP masitinib results in decreased expression of MOB1B mRNA CTD PMID:22747577 NCBI chr13:60,145,168...60,197,916
Ensembl chr13:60,145,366...60,195,463 		JBrowse link
G MPDZ multiple PDZ domain crumbs cell polarity complex component increases expression EXP masitinib results in increased expression of MPDZ mRNA CTD PMID:22747577 NCBI chr11:33,691,434...33,826,500
Ensembl chr11:33,692,296...33,826,437 		JBrowse link
G MYOZ1 myozenin 1 increases expression EXP masitinib results in increased expression of MYOZ1 mRNA CTD PMID:22747577 NCBI chr 4:24,158,532...24,165,416
Ensembl chr 4:24,158,720...24,165,392 		JBrowse link
G NAPG NSF attachment protein gamma decreases expression EXP masitinib results in decreased expression of NAPG mRNA CTD PMID:22747577 NCBI chr 7:76,403,561...76,424,994
Ensembl chr 7:76,403,595...76,423,170 		JBrowse link
G NDUFS1 NADH:ubiquinone oxidoreductase core subunit S1 decreases expression EXP masitinib results in decreased expression of NDUFS1 mRNA CTD PMID:22747577 NCBI chr37:14,680,908...14,713,838
Ensembl chr37:14,683,083...14,713,754 		JBrowse link
G NFKBIA NFKB inhibitor alpha increases expression EXP masitinib results in increased expression of NFKBIA mRNA CTD PMID:22747577 NCBI chr 8:14,100,203...14,103,453
Ensembl chr 8:14,100,671...14,103,433 		JBrowse link
G NRAS NRAS proto-oncogene, GTPase decreases expression EXP masitinib results in decreased expression of NRAS mRNA CTD PMID:22747577 NCBI chr17:52,411,733...52,418,788
Ensembl chr17:52,411,733...52,418,788 		JBrowse link
G NSG1 neuronal vesicle trafficking associated 1 decreases expression EXP masitinib results in decreased expression of NSG1 mRNA CTD PMID:22747577 NCBI chr 3:69,805,646...69,831,200
Ensembl chr 3:69,805,592...69,831,194 		JBrowse link
G NTRK1 neurotrophic receptor tyrosine kinase 1 increases expression EXP masitinib results in increased expression of NTRK1 mRNA CTD PMID:22747577 NCBI chr 7:41,140,931...41,159,326
Ensembl chr 7:41,140,879...41,159,288 		JBrowse link
G OCA2 OCA2 melanosomal transmembrane protein decreases expression EXP masitinib results in decreased expression of OCA2 mRNA CTD PMID:22747577 NCBI chr 3:32,361,825...32,713,631
Ensembl chr 3:32,361,517...32,713,572 		JBrowse link
G OGT O-linked N-acetylglucosamine (GlcNAc) transferase increases expression EXP masitinib results in increased expression of OGT mRNA CTD PMID:22747577 NCBI chr  X:55,821,227...55,857,597
Ensembl chr  X:55,821,234...55,855,502 		JBrowse link
G OXCT1 3-oxoacid CoA-transferase 1 increases expression EXP masitinib results in increased expression of OXCT1 protein CTD PMID:22747577 NCBI chr 4:67,709,846...67,841,737
Ensembl chr 4:67,527,531...67,841,518 		JBrowse link
G PARP14 poly(ADP-ribose) polymerase family member 14 increases expression EXP masitinib results in increased expression of PARP14 mRNA CTD PMID:22747577 NCBI chr33:25,763,282...25,798,284
Ensembl chr33:25,763,255...25,798,198 		JBrowse link
G PCM1 pericentriolar material 1 increases expression EXP masitinib results in increased expression of PCM1 mRNA CTD PMID:22747577 NCBI chr16:41,212,733...41,291,654
Ensembl chr16:41,214,417...41,291,376 		JBrowse link
G PCOLCE2 procollagen C-endopeptidase enhancer 2 decreases expression EXP masitinib results in decreased expression of PCOLCE2 mRNA CTD PMID:22747577 NCBI chr23:38,424,408...38,486,800
Ensembl chr23:38,426,216...38,487,252 		JBrowse link
G PDE6H phosphodiesterase 6H increases expression EXP masitinib results in increased expression of PDE6H mRNA CTD PMID:22747577 NCBI chr27:31,640,731...31,664,494
Ensembl chr27:31,640,737...31,664,401 		JBrowse link
G PDHA1 pyruvate dehydrogenase E1 subunit alpha 1 decreases expression EXP masitinib results in decreased expression of PDHA1 mRNA CTD PMID:22747577 NCBI chr  X:15,338,364...15,354,011
Ensembl chr  X:15,338,202...15,387,458 		JBrowse link
G PDIA3 protein disulfide isomerase family A member 3 increases expression EXP masitinib results in increased expression of PDIA3 protein CTD PMID:22747577 NCBI chr30:10,487,926...10,513,437
Ensembl chr30:10,487,921...10,513,397 		JBrowse link
G PEBP4 phosphatidylethanolamine binding protein 4 increases expression EXP masitinib results in increased expression of PEBP4 mRNA CTD PMID:22747577 NCBI chr25:34,329,160...34,574,086
Ensembl chr25:34,317,421...34,574,066 		JBrowse link
G PECAM1 platelet and endothelial cell adhesion molecule 1 increases expression EXP masitinib results in increased expression of PECAM1 mRNA CTD PMID:22747577 NCBI chr 9:12,166,124...12,219,553
Ensembl chr 9:12,166,775...12,219,778 		JBrowse link
G PHF10 PHD finger protein 10 increases expression EXP masitinib results in increased expression of PHF10 mRNA CTD PMID:22747577 NCBI chr12:71,955,354...71,998,283
Ensembl chr12:71,787,082...71,998,243 		JBrowse link
G POMT1 protein O-mannosyltransferase 1 decreases expression EXP masitinib results in decreased expression of POMT1 mRNA CTD PMID:22747577 NCBI chr 9:52,615,349...52,631,538
Ensembl chr 9:52,615,655...52,630,836 		JBrowse link
G POR cytochrome p450 oxidoreductase increases expression EXP masitinib results in increased expression of POR mRNA CTD PMID:22747577 NCBI chr 6:7,247,780...7,316,282
Ensembl chr 6:7,263,574...7,316,297 		JBrowse link
G PPA1 inorganic pyrophosphatase 1 decreases expression EXP masitinib results in decreased expression of PPA1 protein CTD PMID:22747577 NCBI chr 4:21,145,547...21,189,985
Ensembl chr 4:21,145,547...21,182,748 		JBrowse link
G PRPS2 phosphoribosyl pyrophosphate synthetase 2 decreases expression EXP masitinib results in decreased expression of PRPS2 mRNA CTD PMID:22747577 NCBI chr  X:9,281,686...9,326,551
Ensembl chr  X:9,281,730...9,418,289 		JBrowse link
G PSMB9 proteasome 20S subunit beta 9 increases expression EXP masitinib results in increased expression of PSMB9 mRNA CTD PMID:22747577 NCBI chr12:2,432,287...2,438,920
Ensembl chr12:2,432,505...2,438,069 		JBrowse link
G PSMD6 proteasome 26S subunit, non-ATPase 6 decreases expression EXP masitinib results in decreased expression of PSMD6 protein CTD PMID:22747577 NCBI chr20:27,206,801...27,220,059 JBrowse link
G PSMD9 proteasome 26S subunit, non-ATPase 9 decreases expression EXP masitinib results in decreased expression of PSMD9 mRNA CTD PMID:22747577 NCBI chr26:7,376,154...7,400,655
Ensembl chr26:7,377,413...7,400,573 		JBrowse link
G PTH parathyroid hormone increases expression EXP masitinib results in increased expression of PTH mRNA CTD PMID:22747577 NCBI chr21:36,417,062...36,419,967
Ensembl chr21:36,417,058...36,419,967 		JBrowse link
G PXYLP1 2-phosphoxylose phosphatase 1 decreases expression EXP masitinib results in decreased expression of ACPL2 mRNA CTD PMID:22747577 NCBI chr23:37,145,065...37,197,808
Ensembl chr23:37,145,086...37,196,427 		JBrowse link
G R3HDM2 R3H domain containing 2 increases expression EXP masitinib results in increased expression of R3HDM2 mRNA CTD PMID:22747577 NCBI chr10:1,377,664...1,504,008
Ensembl chr10:1,370,350...1,504,017 		JBrowse link
G RAB44 RAB44, member RAS oncogene family increases expression EXP masitinib results in increased expression of RAB44 mRNA CTD PMID:22747577 NCBI chr12:5,769,056...5,804,963
Ensembl chr12:5,770,882...5,804,949 		JBrowse link
G RASGRP2 RAS guanyl releasing protein 2 increases expression EXP masitinib results in increased expression of RASGRP2 mRNA CTD PMID:22747577 NCBI chr18:52,412,331...52,426,910
Ensembl chr18:52,412,367...52,426,916 		JBrowse link
G RCAN1 regulator of calcineurin 1 increases expression EXP masitinib results in increased expression of RCAN1 mRNA CTD PMID:22747577 NCBI chr31:29,908,046...30,002,412
Ensembl chr31:29,909,388...30,002,418 		JBrowse link
G RGS13 regulator of G protein signaling 13 decreases expression EXP masitinib results in decreased expression of RGS13 mRNA CTD PMID:22747577 NCBI chr38:6,291,146...6,316,662
Ensembl chr38:6,291,182...6,315,198 		JBrowse link
G SAR1B secretion associated Ras related GTPase 1B decreases expression EXP masitinib results in decreased expression of SAR1A mRNA CTD PMID:22747577 NCBI chr11:22,713,459...22,743,190
Ensembl chr11:22,717,942...22,743,124 		JBrowse link
G SCD stearoyl-CoA desaturase decreases expression EXP masitinib results in decreased expression of SCD mRNA CTD PMID:22747577 NCBI chr28:13,112,741...13,129,129
Ensembl chr28:13,113,006...13,125,801 		JBrowse link
G SELENBP1 selenium binding protein 1 increases expression EXP masitinib results in increased expression of SELENBP1 protein CTD PMID:22747577 NCBI chr17:60,410,727...60,418,770
Ensembl chr17:60,410,734...60,418,704 		JBrowse link
G SERPINE2 serpin family E member 2 increases expression EXP masitinib results in increased expression of SERPINE2 mRNA CTD PMID:22747577 NCBI chr37:29,699,551...29,750,151
Ensembl chr37:29,700,024...29,724,228 		JBrowse link
G SFT2D2 SFT2 domain containing 2 decreases expression EXP masitinib results in decreased expression of SFT2D2 mRNA CTD PMID:22747577 NCBI chr 7:30,258,748...30,281,371 JBrowse link
G SLA Src like adaptor increases expression EXP masitinib results in increased expression of SLA mRNA CTD PMID:22747577 NCBI chr13:29,503,304...29,590,679
Ensembl chr13:29,504,867...29,569,773 		JBrowse link
G SLC25A12 solute carrier family 25 member 12 decreases expression EXP masitinib results in decreased expression of SLC25A12 mRNA CTD PMID:22747577 NCBI chr36:16,185,011...16,391,080
Ensembl chr36:16,185,649...16,483,016 		JBrowse link
G SMC5 structural maintenance of chromosomes 5 decreases expression EXP masitinib results in decreased expression of SMC5 mRNA CTD PMID:22747577 NCBI chr 1:87,192,988...87,285,678
Ensembl chr 1:87,194,867...87,285,606 		JBrowse link
G SRR serine racemase increases expression EXP masitinib results in increased expression of SRR mRNA CTD PMID:22747577
G STING1 stimulator of interferon response cGAMP interactor 1 increases expression EXP masitinib results in increased expression of TMEM173 mRNA CTD PMID:22747577 NCBI chr 2:34,783,947...34,792,204
Ensembl chr 2:34,784,232...34,789,072 		JBrowse link
G STOX1 storkhead box 1 increases expression EXP masitinib results in increased expression of STOX1 mRNA CTD PMID:22747577 NCBI chr 4:20,013,893...20,065,480
Ensembl chr 4:20,014,007...20,060,394 		JBrowse link
G STX16 syntaxin 16 increases expression EXP masitinib results in increased expression of STX16 mRNA CTD PMID:22747577 NCBI chr24:43,425,719...43,451,828
Ensembl chr24:43,426,470...43,449,077 		JBrowse link
G STYXL1 serine/threonine/tyrosine interacting like 1 increases expression EXP masitinib results in increased expression of STYXL1 mRNA CTD PMID:22747577 NCBI chr 6:7,323,911...7,389,878
Ensembl chr 6:7,316,477...7,389,842 		JBrowse link
G TARDBP TAR DNA binding protein decreases expression EXP masitinib results in decreased expression of TARDBP protein CTD PMID:22747577 NCBI chr 2:84,987,752...84,998,136
Ensembl chr 2:84,989,952...84,998,593 		JBrowse link
G TBC1D14 TBC1 domain family member 14 decreases expression EXP masitinib results in decreased expression of TBC1D14 mRNA CTD PMID:22747577 NCBI chr 3:58,992,743...59,097,581
Ensembl chr 3:58,926,237...59,097,621 		JBrowse link
G TCN2 transcobalamin 2 increases expression EXP masitinib results in increased expression of TCN2 mRNA CTD PMID:22747577 NCBI chr26:23,693,664...23,710,342
Ensembl chr26:23,693,773...23,709,832 		JBrowse link
G TCP1 t-complex 1 decreases expression EXP masitinib results in decreased expression of TCP1 protein CTD PMID:22747577 NCBI chr 1:49,029,260...49,038,023
Ensembl chr 1:49,029,282...49,038,020 		JBrowse link
G TEAD4 TEA domain transcription factor 4 increases expression EXP masitinib results in increased expression of TEAD4 mRNA CTD PMID:22747577 NCBI chr27:41,744,100...41,783,223
Ensembl chr27:41,748,871...41,803,556 		JBrowse link
G THEMIS2 thymocyte selection associated family member 2 decreases expression EXP masitinib results in decreased expression of THEMIS2 mRNA CTD PMID:22747577 NCBI chr 2:72,465,719...72,501,962
Ensembl chr 2:72,464,026...72,502,928 		JBrowse link
G TM2D2 TM2 domain containing 2 increases expression EXP masitinib results in increased expression of TM2D2 mRNA CTD PMID:22747577 NCBI chr16:26,551,563...26,557,554
Ensembl chr16:26,551,628...26,556,285 		JBrowse link
G TMEM108 transmembrane protein 108 increases expression EXP masitinib results in increased expression of TMEM108 mRNA CTD PMID:22747577 NCBI chr23:29,992,038...30,331,791
Ensembl chr23:29,992,021...30,396,840 		JBrowse link
G TMEM260 transmembrane protein 260 increases expression EXP masitinib results in increased expression of TMEM260 mRNA CTD PMID:22747577 NCBI chr 8:32,238,992...32,309,320
Ensembl chr 8:32,238,988...32,306,317 		JBrowse link
G TNFSF10 TNF superfamily member 10 increases expression EXP masitinib results in increased expression of TNFSF10 mRNA CTD PMID:22747577 NCBI chr34:36,719,249...36,734,989
Ensembl chr34:36,670,849...36,735,060 		JBrowse link
G TNPO1 transportin 1 decreases expression EXP masitinib results in decreased expression of TNPO1 mRNA CTD PMID:22747577 NCBI chr 2:55,795,737...55,859,366
Ensembl chr 2:55,799,907...55,851,213 		JBrowse link
G TNS1 tensin 1 decreases expression EXP masitinib results in decreased expression of TNS1 mRNA CTD PMID:22747577 NCBI chr37:24,578,855...24,776,153
Ensembl chr37:24,581,806...24,808,049 		JBrowse link
G TOX thymocyte selection associated high mobility group box increases expression EXP masitinib results in increased expression of TOX mRNA CTD PMID:22747577 NCBI chr29:9,542,471...9,841,759
Ensembl chr29:9,544,561...9,842,034 		JBrowse link
G TSHB thyroid stimulating hormone subunit beta increases expression EXP masitinib results in increased expression of TSHB mRNA CTD PMID:22747577 NCBI chr17:52,659,137...52,685,388
Ensembl chr17:52,681,357...52,685,390 		JBrowse link
G TSPAN2 tetraspanin 2 increases expression EXP masitinib results in increased expression of TSPAN2 mRNA CTD PMID:22747577 NCBI chr17:52,692,744...52,749,048
Ensembl chr17:52,694,603...52,744,276 		JBrowse link
G TTC38 tetratricopeptide repeat domain 38 increases expression EXP masitinib results in increased expression of TTC38 protein CTD PMID:22747577 NCBI chr10:19,887,285...19,910,347
Ensembl chr10:19,773,373...19,910,683 		JBrowse link
G TTLL1 TTL family tubulin polyglutamylase complex subunit L1 decreases expression EXP masitinib results in decreased expression of TTLL1 mRNA CTD PMID:22747577 NCBI chr10:22,456,150...22,492,375
Ensembl chr10:22,456,146...22,488,505 		JBrowse link
G UCHL3 ubiquitin C-terminal hydrolase L3 increases expression EXP masitinib results in increased expression of UCHL3 protein CTD PMID:22747577 NCBI chr22:29,348,962...29,397,944
Ensembl chr22:29,348,706...29,407,965 		JBrowse link
G UQCC1 ubiquinol-cytochrome c reductase complex assembly factor 1 decreases expression EXP masitinib results in decreased expression of UQCC1 mRNA CTD PMID:22747577 NCBI chr24:24,285,147...24,381,819
Ensembl chr24:24,286,320...24,381,699 		JBrowse link
G UROD uroporphyrinogen decarboxylase increases expression EXP masitinib results in increased expression of UROD protein CTD PMID:22747577 NCBI chr15:15,313,808...15,317,130
Ensembl chr15:15,312,674...15,320,010 		JBrowse link
G UROS uroporphyrinogen III synthase increases expression EXP masitinib results in increased expression of UROS mRNA CTD PMID:22747577 NCBI chr28:34,952,074...34,983,532
Ensembl chr28:34,948,003...34,983,532 		JBrowse link
G VCPKMT valosin containing protein lysine methyltransferase decreases expression EXP masitinib results in decreased expression of VCPKMT mRNA CTD PMID:22747577 NCBI chr 8:26,611,333...26,636,700
Ensembl chr 8:26,625,677...26,636,316 		JBrowse link
G WAPL WAPL cohesin release factor decreases expression EXP masitinib results in decreased expression of WAPAL mRNA CTD PMID:22747577 NCBI chr 4:34,219,644...34,297,456
Ensembl chr 4:34,219,645...34,302,839 		JBrowse link
G YWHAZ tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta increases expression EXP masitinib results in increased expression of YWHAZ protein CTD PMID:22747577 NCBI chr13:2,729,404...2,764,422 JBrowse link
G ZNF23 zinc finger protein 23 increases expression EXP masitinib results in increased expression of ZNF23 mRNA CTD PMID:22747577 NCBI chr 5:77,246,374...77,260,761
Ensembl chr 5:77,246,667...77,260,350 		JBrowse link
melittin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G HEXB hexosaminidase subunit beta multiple interactions
increases secretion		 EXP G(M1) Ganglioside inhibits the reaction [Melitten results in increased secretion of HEXB protein]; sialogangliosides inhibits the reaction [Melitten results in increased secretion of HEXB protein]; trisialoganglioside GT1 inhibits the reaction [Melitten results in increased secretion of HEXB protein] CTD PMID:21334356 NCBI chr 2:57,221,809...57,248,432
Ensembl chr 2:57,222,186...57,248,417 		JBrowse link
ML-7 term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB1 ATP binding cassette subfamily B member 1 multiple interactions EXP [ML 7 results in decreased activity of MYLK protein] affects the reaction [ABCB1 protein affects the transport of Digoxin] CTD PMID:20510202 NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727 		JBrowse link
G MYLK myosin light chain kinase multiple interactions EXP [ML 7 results in decreased activity of MYLK protein] affects the reaction [ABCB1 protein affects the transport of Digoxin] CTD PMID:20510202 NCBI chr33:26,663,991...26,867,370
Ensembl chr33:26,664,800...26,843,181 		JBrowse link
N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G IL6 interleukin 6 multiple interactions
decreases expression		 EXP N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Amphotericin B results in increased expression of IL6 protein]
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide results in decreased expression of IL6 protein		 CTD PMID:24105867 NCBI chr14:36,474,268...36,478,519
Ensembl chr14:36,473,394...36,478,519 		JBrowse link
G PRKACB protein kinase cAMP-activated catalytic subunit beta multiple interactions EXP N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Amphotericin B results in increased expression of PRKACG protein] CTD PMID:24105867 NCBI chr 6:63,615,445...63,729,386
Ensembl chr 6:63,618,323...63,730,146 		JBrowse link
nicotinamide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G PPARG peroxisome proliferator activated receptor gamma increases expression
multiple interactions		 EXP Niacinamide results in increased expression of PPARG protein
Resveratrol inhibits the reaction [Niacinamide results in increased expression of PPARG protein]		 CTD PMID:22539994 NCBI chr20:6,134,618...6,265,481
Ensembl chr20:6,050,357...6,207,981 		JBrowse link
G RUNX2 RUNX family transcription factor 2 increases acetylation
multiple interactions
decreases expression		 EXP Niacinamide results in increased acetylation of RUNX2 protein
Niacinamide inhibits the reaction [SIRT1 protein binds to RUNX2 protein]; Resveratrol inhibits the reaction [Niacinamide inhibits the reaction [SIRT1 protein binds to RUNX2 protein]]; Resveratrol inhibits the reaction [Niacinamide results in decreased expression of RUNX2 protein]; Resveratrol inhibits the reaction [Niacinamide results in increased acetylation of RUNX2 protein]		 CTD PMID:22539994 NCBI chr12:13,723,535...13,842,565
Ensembl chr12:13,628,539...13,840,785
Ensembl chr12:13,628,539...13,840,785 		JBrowse link
G SIRT1 sirtuin 1 decreases expression
multiple interactions		 EXP Niacinamide results in decreased expression of SIRT1 protein
Niacinamide inhibits the reaction [SIRT1 protein binds to RUNX2 protein]; Resveratrol inhibits the reaction [Niacinamide inhibits the reaction [SIRT1 protein binds to RUNX2 protein]]; Resveratrol inhibits the reaction [Niacinamide results in decreased expression of SIRT1 protein]		 CTD PMID:22539994 NCBI chr 4:19,188,616...19,220,031
Ensembl chr 4:19,188,675...19,218,279 		JBrowse link
ouabain term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G REN renin decreases secretion
multiple interactions		 EXP Ouabain results in decreased secretion of REN protein
Vanadates inhibits the reaction [Ouabain results in decreased secretion of REN protein]		 CTD PMID:6093556 NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012 		JBrowse link
quercetin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB1 ATP binding cassette subfamily B member 1 multiple interactions EXP Quercetin inhibits the reaction [ABCB1 protein results in increased secretion of Ritonavir] CTD PMID:15266218 NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727 		JBrowse link
G CPNE6 copine 6 decreases activity EXP Quercetin results in decreased activity of DHRS4 protein CTD PMID:17827741 NCBI chr 8:4,046,532...4,058,498
Ensembl chr 8:4,046,544...4,084,744 		JBrowse link
G HSP70 heat shock protein 70 decreases expression EXP Quercetin results in decreased expression of HSP70 protein CTD PMID:17009600 NCBI chr12:1,285,282...1,287,670 JBrowse link
rifampicin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB1 ATP binding cassette subfamily B member 1 increases expression EXP Rifampin results in increased expression of ABCB1 mRNA; Rifampin results in increased expression of ABCB1 protein CTD PMID:22620706 NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727 		JBrowse link
G NR1I2 nuclear receptor subfamily 1 group I member 2 increases activity EXP Rifampin results in increased activity of NR1I2 protein CTD PMID:27732639 NCBI chr33:23,444,367...23,456,405
Ensembl chr33:23,432,690...23,455,347 		JBrowse link
SR 144528 term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CNR2 cannabinoid receptor 2 multiple interactions EXP SR 144528 binds to and results in decreased activity of CNR2 protein CTD PMID:21871882 NCBI chr 2:75,640,636...75,662,000
Ensembl chr 2:75,658,999...75,660,126 		JBrowse link
tolfenamic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G PTGS2 prostaglandin-endoperoxide synthase 2 decreases expression EXP tolfenamic acid results in decreased expression of PTGS2 mRNA CTD PMID:15198222 NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903 		JBrowse link
tunicamycin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G HSP90B1 heat shock protein 90 beta family member 1 increases expression EXP Tunicamycin results in increased expression of HSP90B1 protein CTD PMID:17416481 NCBI chr15:42,456,793...42,474,122
Ensembl chr15:42,456,764...42,579,311 		JBrowse link
G HSPA5 heat shock protein family A (Hsp70) member 5 increases expression EXP Tunicamycin results in increased expression of HSPA5 protein CTD PMID:17416481 NCBI chr 9:57,850,870...57,855,607
Ensembl chr 9:57,850,922...57,855,257 		JBrowse link
Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 501
    role 501
      biological role 501
        biochemical role 459
          enzyme inhibitor 370
            EC 2.* (transferase) inhibitor 184
              EC 2.1.* (C1-transferase) inhibitor + 0
              EC 2.10.* (Mo- or W-containing group transferase) inhibitor 0
              EC 2.2.* (aldehyde or ketone transferase) inhibitor + 0
              EC 2.3.* (acyltransferase) inhibitor + 9
              EC 2.4.* (glycosyltransferase) inhibitor + 3
              EC 2.5.* (non-methyl-alkyl or aryl transferase) inhibitor + 0
              EC 2.6.* (nitrogenous group transferase) inhibitor + 0
              EC 2.7.* (P-containing group transferase) inhibitor + 179
              EC 2.8.* (S-containing group transferase) inhibitor 0
              EC 2.9.* (Se-containing group transferase) inhibitor 0
              OSMI-1 0
paths to the root